-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L8gw9AgL+JBAWq/GsfU5RJ8/NcV/B0HIoc8mrS/bMDx0ap5yw5SNmDy82S7uCFCU fizfNrJsO8aiWje1PFRL8g== /in/edgar/work/20000717/0000908180-00-000012/0000908180-00-000012.txt : 20000920 0000908180-00-000012.hdr.sgml : 20000920 ACCESSION NUMBER: 0000908180-00-000012 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20000717 ITEM INFORMATION: FILED AS OF DATE: 20000717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CFI PROSERVICES INC CENTRAL INDEX KEY: 0000908180 STANDARD INDUSTRIAL CLASSIFICATION: [7372 ] IRS NUMBER: 930704365 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-21980 FILM NUMBER: 674049 BUSINESS ADDRESS: STREET 1: 400 S W SIXTH AVE STREET 2: SUITE 200 CITY: PORTLAND STATE: OR ZIP: 97204 BUSINESS PHONE: 5032747280 MAIL ADDRESS: STREET 1: 400 S W SIXTH AVE STREET 2: STE 200 CITY: PORTLAND STATE: OR ZIP: 97204 8-K 1 0001.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - -------------------------------------------------------------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 12 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 17, 2000 CONCENTREX INCORPORATED (exact name of registrant as specified in its charter) Oregon 0-21980 93-0704365 (State or other jurisdiction of (Commission (IRS Employer incorporation or organization) File Number) Identification No.) 400 SW Sixth Avenue, Portland, Oregon 97204 (Address of principal executive offices) (zip code) Registrant's telephone number, including area code: (503)274-7280 - -------------------------------------------------------------------------------- Item 5. Other Matters ------------- (a) On July 17, 2000, the Registrant issued a press release that is attached hereto as Exhibit 99.1, and which is incorporated herein by reference. (b) Exhibits. 99.1 - Press Release, dated July 17, 2000, issued by Concentrex Incorporated. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CONCENTREX INCORPORATED (Registrant) DATE: July 17, 2000 /s/ Jeffrey P. Strickler ------------------------ Jeffrey P. Strickler Vice President and General Counsel EX-99 2 0002.txt EXHIBIT 99.1 CONTACTS: MEDIA: Tom Gauntt INVESTORS: Deanna Whitestone Concentrex Incorporated Concentrex Incorporated Public Relations Investor Relations (503) 274-7280, ex. 2177 (503) 274-7280, ex 2418 TGAUNTT@CONCENTREX.COM DWHITESTONE@CONCENTREX.COM John Pensec Victoria P. Weyand John H. Harland Company John H. Harland Company Director of Corporate Vice President of Communications Communications (770) 593-5543 (770) 593-5127 jpensec@harland.net vweyand@harland.net JOHN H. HARLAND BUYS CONCENTREX FOR $7.00 PER SHARE PORTLAND, ORE. - JULY 17, 2000--Concentrex Incorporated (NASDAQ: CCTX) announced today that it has reached an agreement with John H. Harland Company (NYSE: JH) under the terms of which Harland will pay approximately $140 million for Concentrex, taking into account the Company's loan obligations and transaction-related expenses. The transaction will take the form of a tender offer of $7.00 per Concentrex share and is expected to close in August. The closing is subject to receiving a majority of Concentrex's outstanding shares in the tender offer, receiving regulatory approval and other closing conditions. "There is little overlap between Harland's software division and Concentrex in terms of products, and we believe this acquisition provides the best opportunity for our employees and our customers," said Matt Chapman, Concentrex Chairman and CEO. "Concentrex has been under extreme pressure because of concerns over our financial situation and a transaction of this type was essential for the Company. Getting the benefit of Harland's extremely strong balance sheet and cash generation will address this financial concern, while providing a material premium over the current share price for our shareholders." Concentrex also announced today that its second quarter results are expected to be substantially below analyst expectations, and, as a result, it is in default under the loan covenants with its lenders. "Our financial position with our lenders is a principal reason we have chosen to sell the company," added Chapman. Allen & Co. was retained by Concentrex to assist it in pursuing strategic alternatives and served as investment advisor in this transaction. (more) ABOUT CONCENTREX INCORPORATED Concentrex Incorporated, based in Portland, Oregon, is a leading provider of technology-powered solutions to deliver financial services, including a broad range of traditional software and services integrated with leading e-commerce solutions that already enable its customers to serve more than one million home banking customers. Concentrex serves over 5,000 financial institutions of all types and sizes in the United States. Concentrex has major offices in 11 additional cities across the country. Its World Wide WEB SITE IS WWW.CONCENTREX.COM ABOUT HARLAND ATLANTA-BASED JOHN H. HARLAND COMPANY (WWW.HARLAND.NET) is listed on the New York Stock Exchange under the symbol "JH." Harland is a leading provider of checks, financial software and direct marketing to the financial institution market. Scantron Corporation (WWW.SCANTRON.COM), a wholly owned subsidiary, is a leading provider of software services and systems for the collection, management and interpretation of data to the financial, commercial and educational markets. THIS ANNOUNCEMENT IS NEITHER AN OFFER TO PURCHASE NOR A SOLICITATION OF AN OFFER TO SELL SHARES OF CONCENTREX INCORPORATED. AT THE TIME THE OFFER IS COMMENCED HARLAND WILL FILE A TENDER OFFER STATEMENT WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (SEC) AND CONCENTREX WILL FILE A SOLICITATION/RECOMMENDATION STATEMENT WITH RESPECT TO THE OFFER. CONCENTREX SHAREHOLDERS ARE ADVISED TO READ THE TENDER OFFER STATEMENT REGARDING THE ACQUISITION OF CONCENTREX REFERENCED IN THIS PRESS RELEASE, AND THE RELATED SOLICITATION/RECOMMENDATION STATEMENT. THE TENDER OFFER STATEMENT (INCLUDING AN OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED TENDER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT WILL CONTAIN IMPORTANT INFORMATION WHICH SHOULD BE READ CAREFULLY BEFORE ANY DECISION IS MADE WITH RESPECT TO THE OFFER. THESE DOCUMENTS WILL BE MADE AVAILABLE TO ALL STOCKHOLDERS OF CONCENTREX AT NO EXPENSE TO THEM. THESE DOCUMENTS WILL ALSO BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT WWW.SEC.GOV. THIS PRESS RELEASE CONTAINS STATEMENTS WHICH MAY CONSTITUTE "FORWARD-LOOKING STATEMENTS" WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. THESE STATEMENTS INCLUDE STATEMENTS REGARDING THE INTENT, BELIEF OR CURRENT EXPECTATIONS OF JOHN H. HARLAND COMPANY, CONCENTREX INCORPORATED AND MEMBERS OF THEIR RESPECTIVE MANAGEMENT, AS WELL AS THE ASSUMPTIONS ON WHICH SUCH STATEMENTS ARE BASED. PROSPECTIVE INVESTORS ARE CAUTIONED THAT ANY SUCH FORWARD-LOOKING STATEMENTS ARE NOT GUARANTEES OF FUTURE PERFORMANCE AND INVOLVE RISKS AND UNCERTAINTIES AND THAT ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE CONTEMPLATED BY SUCH FORWARD-LOOKING STATEMENTS. REFERENCE IS MADE TO THE RISK FACTORS AND CAUTIONARY STATEMENTS OF HARLAND'S FORM 10-K AND FORM 10-Q AND TO CONCENTREX'S SECURITIES AND EXCHANGE COMMISSION REPORTS FILED UNDER THE SECURITIES EXCHANGE ACT. ### -----END PRIVACY-ENHANCED MESSAGE-----